Cambridge Cognition Holdings Plc develops and markets digital solutions for assessing brain health in the United States, United Kingdom, European Union, and internationally. Its offerings include objective measures of cognitive function correlated to neural networks, voice analysis for monitoring neurological and psychiatric disorders, and high-frequency testing that detects fluctuations in brain health through short tasks at regular intervals. The company also provides electronic questionnaires and scales (eCOA), bespoke digital questionnaires for data collection within tight deadlines, and data quality management. Incorporated in 2012, it is headquartered in Cambridge, United Kingdom.